Ocean Biomedical, Inc.

Ocean Biomedical, Inc. (Nasdaq: OCEA) is a clinical-stage biopharmaceutical company that completed its business combination with blank-check company Gesture Holdings Corp., sponsored by Gesture Holdings LLC, in February 2023. Gesture Holdings priced its initial public offering in 2021, targeting the life sciences and healthcare sector. Ocean Biomedical, which traces its research origins to Brown University, is developing therapeutic candidates across oncology, pulmonary fibrosis, and infectious disease indications. The company filed its inaugural 10-K with the SEC on March 31, 2023, covering its first reporting period as a publicly traded entity following the de-SPAC closing. Sign up at SpacDesk for complete filing history, deal timelines, and analytics on OCEA and the broader SPAC universe.